BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21258245)

  • 1. Causes and consequences of deviation from multidisciplinary care in thoracic oncology.
    Osarogiagbon RU; Phelps G; McFarlane J; Bankole O
    J Thorac Oncol; 2011 Mar; 6(3):510-6. PubMed ID: 21258245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care.
    Riedel RF; Wang X; McCormack M; Toloza E; Montana GS; Schreiber G; Kelley MJ
    J Thorac Oncol; 2006 Sep; 1(7):692-6. PubMed ID: 17409938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer.
    Giroux Leprieur E; Labrune S; Giraud V; Gendry T; Cobarzan D; Chinet T
    Clin Lung Cancer; 2012 Sep; 13(5):363-8. PubMed ID: 22264658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timeliness of lung cancer diagnosis and treatment: a single-center experience.
    Rao SS; Saha S
    Asian Cardiovasc Thorac Ann; 2019 Oct; 27(8):670-676. PubMed ID: 31569945
    [No Abstract]   [Full Text] [Related]  

  • 5. Delays during the diagnostic evaluation and treatment of lung cancer.
    Chandra S; Mohan A; Guleria R; Singh V; Yadav P
    Asian Pac J Cancer Prev; 2009; 10(3):453-6. PubMed ID: 19640190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of multidisciplinary lung cancer practice.
    Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in comorbidity and clinical management in patients newly diagnosed with lung cancer in four Scottish centers.
    Grose D; Devereux G; Brown L; Jones R; Sharma D; Selby C; Morrison DS; Docherty K; McIntosh D; Louden G; Downer P; Nicolson M; Milroy R;
    J Thorac Oncol; 2011 Mar; 6(3):500-9. PubMed ID: 21258251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaps in Guideline-Concordant Use of Diagnostic Tests Among Lung Cancer Patients.
    Flanagan MR; Varghese TK; Backhus LM; Wood DE; Mulligan MS; Cheng AM; Flum DR; Farjah F
    Ann Thorac Surg; 2015 Dec; 100(6):2006-12. PubMed ID: 26507425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaps in optimal care for lung cancer.
    Vinod SK; O'Connell DL; Simonella L; Delaney GP; Boyer M; Peters M; Miller D; Supramaniam R; McCawley L; Armstrong B
    J Thorac Oncol; 2008 Aug; 3(8):871-9. PubMed ID: 18670305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delays in the diagnosis and treatment of lung cancer.
    Salomaa ER; Sällinen S; Hiekkanen H; Liippo K
    Chest; 2005 Oct; 128(4):2282-8. PubMed ID: 16236885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function.
    Dickhoff C; Hartemink KJ; van de Ven PM; van Reij EJ; Senan S; Paul MA; Smit EF; Dahele M
    Lung Cancer; 2014 Aug; 85(2):218-23. PubMed ID: 24976333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer in Victoria: are we making progress?
    Mitchell PL; Thursfield VJ; Ball DL; Richardson GE; Irving LB; Torn-Broers Y; Giles GG; Wright GM
    Med J Aust; 2013 Nov; 199(10):674-9. PubMed ID: 24237097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-cell lung cancer: prognostic factors and changing treatment over 15 years.
    Gaspar LE; McNamara EJ; Gay EG; Putnam JB; Crawford J; Herbst RS; Bonner JA
    Clin Lung Cancer; 2012 Mar; 13(2):115-22. PubMed ID: 22000695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thoracic multidisciplinary tumor board routinely impacts therapeutic plans in patients with lung and esophageal cancer: a prospective cohort study.
    Schmidt HM; Roberts JM; Bodnar AM; Kunz S; Kirtland SH; Koehler RP; Hubka M; Low DE
    Ann Thorac Surg; 2015 May; 99(5):1719-24. PubMed ID: 25678503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a lung cancer care coordination program on timeliness of care.
    Alsamarai S; Yao X; Cain HC; Chang BW; Chao HH; Connery DM; Deng Y; Garla VN; Hunnibell LS; Kim AW; Obando JA; Taylor C; Tellides G; Rose MG
    Clin Lung Cancer; 2013 Sep; 14(5):527-34. PubMed ID: 23827516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
    Nadpara P; Madhavan SS; Tworek C
    Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study.
    Vergnenegre A; Smit EF; Toy E; Parente B; Schmitz S; Kraaij K; Soldatenkova V; Visseren-Grul C; Zanotti G; Taipale K; Moro-Sibilot D
    Curr Med Res Opin; 2012 Aug; 28(8):1253-62. PubMed ID: 22697276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implementation of the German guideline for the prevention, diagnosis, treatment and follow-up of non-small cell lung cancer at the Diakoniekrankenhaus Halle/Saale].
    Witzmann M; Litwinenko KP; Fischbeck O; Schütte W
    Pneumologie; 2013 Dec; 67(12):683-7. PubMed ID: 24222066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thoracic oncology: annual review].
    Sculier JP; Berghmans T; Meert AP
    Rev Med Brux; 2013; 34(2):100-11. PubMed ID: 23755717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.